Cryptococcus neoformans host adaptation: Toward biological evidence of dormancy

mBio

Volumn 6, Issue 2, 2015, Pages

  Alanio, Alexandre ^a,b,c,d   Vernel Pauillac, Frédérique ^a,b   Sturny Leclère, Aude ^a,b   Dromer, Françoise ^a,b  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DIVISION; CELL GROWTH; CELL INTERACTION; CELL SELECTION; CELL SUBPOPULATION; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DORMANCY; GENE EXPRESSION; HOST PATHOGEN INTERACTION; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MALE; MICROBIAL DIVERSITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SERUM; YEAST CELL; ANIMAL; DISEASE MODEL; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; MICROSCOPY; PATHOLOGY;

EQUIDAE; FILOBASIDIELLA NEOFORMANS; MAMMALIA; MURINAE; NEMATODA; PROTOFUNGI;

ANIMALS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HOST-PATHOGEN INTERACTIONS; MACROPHAGES; MALE; MICE; MICROBIAL VIABILITY; MICROSCOPY;

EID: 84928812870     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02580-14     Document Type: Article

References (79)

1. Casadevall A, Steenbergen JN, Nosanchuk JD. 2003. “Ready made” virulence and “dual use” virulence factors in pathogenic environmental fungi—the Cryptococcus neoformans paradigm. Curr Opin Microbiol 6:332–337. http://dx.doi.org/10.1016/S1369-5274(03)00082-1.
2. Steenbergen JN, Shuman HA, Casadevall A. 2001. Cryptococcus neofor-mans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci U S A 98:15245–15250. http://dx.doi.org/10.1073/pnas.261418798.
3. Derengowski Lda S, Paes HC, Albuquerque P, Tavares AH, Fernandes L, Silva-Pereira I, Casadevall A. 2013. The transcriptional response of Cryptococcus neoformans to ingestion by Acanthamoeba castellanii and macrophages provides insights into the evolutionary adaptation to the mammalian host. Eukaryot Cell 12:761–774. http://dx.doi.org/10.1128/EC.00073-13.
4. Frager SZ, Chrisman CJ, Shakked R, Casadevall A. 2010. Paramecium species ingest and kill the cells of the human pathogenic fungus Crypto-coccus neoformans. Med Mycol 48:775–779. http://dx.doi.org/10.3109/13693780903451810.
5. Fries BC, Taborda CP, Serfass E, Casadevall A. 2001. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. J Clin Invest 108:1639–1648. http://dx.doi.org/10.1172/JCI13407.
6. García-Rodas R, Zaragoza O. 2012. Catch me if you can: phagocytosis and killing avoidance by Cryptococcus neoformans. FEMS Immunol Med Microbiol 64:147–161. http://dx.doi.org/10.1111/j.1574-695X.2011.00871.x.
7. Charlier C, Nielsen K, Daou S, Brigitte M, Chretien F, Dromer F. 2009. Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun 77:120–127. http://dx.doi.org/10.1128/IAI.01065-08.
8. Santangelo R, Zoellner H, Sorrell T, Wilson C, Donald C, Djordjevic J, Shounan Y, Wright L. 2004. Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model. Infect Immun 72:2229–2239. http://dx.doi.org/10.1128/IAI.72.4.2229-2239.2004.
9. Kronstad JW, Attarian R, Cadieux B, Choi J, D’Souza CA, Griffiths EJ, Geddes JM, Hu G, Jung WH, Kretschmer M, Saikia S, Wang J. 2011. Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box. Nat Rev Microbiol 9:193–203. http://dx.doi.org/10.1038/nrmicro2522.
10. Goldman DL, Khine H, Abadi J, Lindenberg DJ, Pirofski La, Niang R, Casadevall A. 2001. Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics 107:E66. http://dx.doi.org/10.1542/peds.107.5.e66.
11. Baker RD. 1976. The primary pulmonary lymph node complex of crytp-tococcosis. Am J Clin Pathol 65:83–92.
12. Garcia-Hermoso D, Janbon G, Dromer F. 1999. Epidemiological evidence for dormant Cryptococcus neoformans infection. J Clin Microbiol 37:3204–3209.
13. Dromer F, Ronin O, Dupont B. 1992. Isolation of Cryptococcus neofor-mans var. gattii from an Asian patient in France: evidence for dormant infection in healthy subjects. J Med Vet Mycol 30:395–397. http://dx.doi.org/10.1080/02681219280000511.
14. Dromer F, Casadevall A, Perfect J, Sorrell T. 2010. Cryptococcus neoformans: latency and disease, p 429. In Heitman J, Kozel TR, Kwon-Chung KJ, Perfect JR, Casadevall A (ed), Cryptococcus: from human pathogen to model yeast. ASM Press, Washington, DC.
15. Eisenman HC, Casadevall A, McClelland EE. 2007. New insights on the pathogenesis of invasive Cryptococcus neoformans infection. Curr Infect Dis Rep 9:457–464. http://dx.doi.org/10.1007/s11908-007-0070-8.
16. Chrétien F, Lortholary O, Kansau I, Neuville S, Gray F, Dromer F. 2002. Pathogenesis of cerebral Cryptococcus neoformans infection after funge-mia. J Infect Dis 186:522–530. http://dx.doi.org/10.1086/341564.
17. French N, Gray K, Watera C, Nakiyingi J, Lugada E, Moore M, Lalloo D, Whitworth JA, Gilks CF. 2002. Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS 16:1031–1038. http://dx.doi.org/10.1097/00002030-200205030-00009.
18. Olszewski MA, Zhang Y, Huffnagle GB. 2010. Mechanisms of crypto-coccal virulence and persistence. Future Microbiol 5:1269–1288. http://dx.doi.org/10.2217/fmb.10.93.
19. Alanio A, Desnos-Ollivier M, Dromer F. 2011. Dynamics of Cryptococcus neoformans-macrophage interactions reveal that fungal background influences outcome during cryptococcal meningoencephalitis in humans. mBio 2:e00158–11. http://dx.doi.org/10.1128/mBio.00158-11.
20. Feldmesser M, Kress Y, Novikoff P, Casadevall A. 2000. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun 68:4225–4237. http://dx.doi.org/10.1128/IAI.68.7.4225-4237.2000.
21. Hu G, Cheng P-Y, Sham A, Perfect JR, Kronstad JW. 2008. Metabolic adaptation in Cryptococcus neoformans during early murine pulmonary infection. Mol Microbiol 69:1456–1475. http://dx.doi.org/10.1111/j.1365-2958.2008.06374.x.
22. Okagaki LH, Strain AK, Nielsen JN, Charlier C, Baltes NJ, Chrétien F, Heitman J, Dromer F, Nielsen K. 2010. Cryptococcal cell morphology affects host cell interactions and pathogenicity. PLoS Pathog 6:e1000953. http://dx.doi.org/10.1371/journal.ppat.1000953.
23. Zaragoza O, García-Rodas R, Nosanchuk JD, Cuenca-Estrella M, Rodríguez-Tudela JL, Casadevall A. 2010. Fungal cell gigantism during mammalian infection. PLoS Pathog 6:e1000945. http://dx.doi.org/10.1371/journal.ppat.1000945.
24. Crabtree JN, Okagaki LH, Wiesner DL, Strain AK, Nielsen JN, Nielsen K. 2012. Titan cell production enhances the virulence of Cryptococcus neoformans. Infect Immun 80:3776–3785. http://dx.doi.org/10.1128/IAI.00507-12.
25. Lortholary O, Improvisi L, Nicolas M, Provost F, Dupont B, Dromer F. 1999. Fungemia during murine cryptococcosis sheds some light on pathophysiology. Med Mycol 37:169–174. http://dx.doi.org/10.1080/j.1365-280X.1999.00215.x.
26. Neuville S, Lortholary O, Dromer F. 2000. Do kinetics of the humoral response to Cryptococcus neoformans proteins during murine cryptococcosis reflect outcome? Infect Immun 68:3724–3726. http://dx.doi.org/10.1128/IAI.68.6.3724-3726.2000.
27. Clemons KV, Stevens DA. 2010. Cryptococcosis in experimental animals: lessons learned, p 473–488. In Heitman J, Kozel TR, Kwon-Chung KJ, Perfect JR, Casadevall A (ed), Cryptococcus: from human pathogen to model yeast. ASM Press, Washington, DC.
28. Lin X, Heitman J. 2006. The biology of the Cryptococcus neoformans species complex. Annu Rev Microbiol 60:69–105. http://dx.doi.org/10.1146/annurev.micro.60.080805.142102.
29. Ou X-T, Wu J-Q, Zhu L-P, Guan M, Xu B, Hu X-P, Wang X, Weng X-H. 2011. Genotypes coding for mannose-binding lectin deficiency correlated with cryptococcal meningitis in HIV-uninfected Chinese patients. J Infect Dis 203:1686–1691. http://dx.doi.org/10.1093/infdis/jir152.
30. Hu X-P, Wu J-Q, Zhu L-P, Wang X, Xu B, Wang R-Y, Ou X-T, Weng X-H. 2012. Association of Fcy receptor IIB polymorphism with cryptococcal meningitis in HIV-uninfected Chinese patients. PLoS One 7:e42439. http://dx.doi.org/10.1371/journal.pone.0042439.
31. Dromer F, Mathoulin-Pélissier S, Launay O, Lortholary O, Group F. 2007. Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS Med 4:e21. http://dx.doi.org/10.1371/journal.pmed.0040021.
32. Levitz SM, Dupont MP, Smail EH. 1994. Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans. Infect Immun 62:194–202.
33. Ma LL, Wang CL, Neely GG, Epelman S, Krensky AM, Mody CH. 2004. NK cells use perforin rather than granulysin for anticryptococcal activity. J Immunol 173:3357–3365. http://dx.doi.org/10.4049/jimmunol.173.5.3357.
34. Schein JE, Tangen KL, Chiu R, Shin H, Lengeler KB, MacDonald WK, Bosdet I, Heitman J, Jones SJ, Marra MA, Kronstad JW. 2002. Physical maps for genome analysis of serotype A and D strains of the fungal pathogen Cryptococcus neoformans. Genome Res 12:1445-1453. http://dx.doi.org/10.1101/gr.81002.
35. Litvintseva AP, Mitchell TG. 2012. Population genetic analyses reveal the African origin and strain variation of Cryptococcus neoformans var. grubii. PLoS Pathog 8:e1002495. http://dx.doi.org/10.1371/journal.ppat.1002495.
36. Feldmesser M, Rivera J, Kress Y, Kozel TR, Casadevall A. 2000. Antibody interactions with the capsule of Cryptococcus neoformans. Infect Immun 68:3642–3650. http://dx.doi.org/10.1128/IAI.68.6.3642-3650.2000.
37. Garcia-Hermoso D, Dromer F, Janbon G. 2004. Cryptococcus neoformans capsule structure evolution in vitro and during murine infection. Infect Immun 72:3359–3365. http://dx.doi.org/10.1128/IAI.72.6.3359-3365.2004.
38. Clancy CJ, Nguyen MH, Alandoerffer R, Cheng S, Iczkowski K, Richardson M, Graybill JR. 2006. Cryptococcus neoformans var. grubii isolates recovered from persons with AIDS demonstrate a wide range of virulence during murine meningoencephalitis that correlates with the expression of certain virulence factors. Microbiology 152:2247–2255. http://dx.doi.org/10.1099/mic.0.28798-0.
39. Liaw S-J, Wu H-C, Hsueh PR. 2010. Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility. Clin Microbiol Infect 16:696–703. http://dx.doi.org/10.1111/j.1469-0691.2009.02930.x.
40. Kozel TR, Pfrommer GS, Guerlain AS, Highison BA, Highison GJ. 1988. Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3. Infect Immun 56:2794–2800.
41. Ma H, Hagen F, Stekel DJ, Johnston SA, Sionov E, Falk R, Polacheck I, Boekhout T, May RC. 2009. The fatal fungal outbreak on Vancouver Island is characterized by enhanced intracellular parasitism driven by mi-tochondrial regulation. Proc Natl Acad Sci U S A 106:12980–12985. http://dx.doi.org/10.1073/pnas.0902963106.
42. Ormerod KL, Morrow CA, Chow EW, Lee IR, Arras SD, Schirra HJ, Cox GM, Fries BC, Fraser JA. 2013. Comparative genomics of serial isolates of Cryptococcus neoformans reveals gene associated with carbon utilization and virulence. G3 (Bethesda) 3:675–686. http://dx.doi.org/10.1534/g3.113.005660.
43. Desnos-Ollivier M, Patel S, Spaulding AR, Charlier C, Garcia-Hermoso D, Nielsen K, Dromer F. 2010. Mixed infections and in vivo evolution in the human fungal pathogen Cryptococcus neoformans. mBio 1:e00091-10. http://dx.doi.org/10.1128/mBio.00091-10.
44. Charlier C, Chrétien F, Baudrimont M, Mordelet E, Lortholary O, Dromer F. 2005. Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am JPathol 166:421–432. http://dx.doi.org/10.1016/S0002-9440(10)62265-1.
45. Steen BR, Zuyderduyn S, Toffaletti DL, Marra M, Jones SJ, Perfect JR, Kronstad J. 2003. Cryptococcus neoformans gene expression during experimental cryptococcal meningitis. Eukaryot Cell 2:1336–1349. http://dx.doi.org/10.1128/EC.2.6.1336-1349.2003.
46. Dworkin J, Shah IM. 2010. Exit from dormancy in microbial organisms. Nat Rev Microbiol 8:890–896. http://dx.doi.org/10.1038/nrmicro2453.
47. Chao MC, Rubin EJ. 2010. Letting sleeping dos lie: does dormancy play a role in tuberculosis? Annu Rev Microbiol 64:293–311. http://dx.doi.org/10.1146/annurev.micro.112408.134043.
48. Keren I, Minami S, Rubin E, Lewis K. 2011. Characterization and tran-scriptome analysis of Mycobacterium tuberculosis persisters. mBio 2:e00100–11. http://dx.doi.org/10.1128/mBio.00100-11.
49. Murphy DJ, Brown JR. 2007. Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. BMC Infect Dis 7:84. http://dx.doi.org/10.1186/1471-2334-7-84.
50. Markus MB. 2011. The hypnozoite concept, with particular reference to malaria. Parasitol Res 108:247–252. http://dx.doi.org/10.1007/s00436-010-2072-y.
51. Gray JV, Petsko GA, Johnston GC, Ringe D, Singer RA, Werner-Washburne M. 2004. “Sleeping beauty”: quiescence in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 68:187–206. http://dx.doi.org/10.1128/MMBR.68.2.187-206.2004.
52. Arcangioli B, Ben Hassine S. 2009. Unrepaired oxidative DNA damage induces an ATR/ATM apoptotic-like response in quiescent fission yeast. Cell Cycle 8:2326–2331. http://dx.doi.org/10.4161/cc.8.15.9147.
53. Lamarre C, Sokol S, Debeaupuis J-P, Henry C, Lacroix C, Glaser P, Coppée J-Y, François J-M, Latgé J-P. 2008. Transcriptomic analysis of the exit from dormancy of Aspergillus fumigatus conidia. BMC Genomics 9:417. http://dx.doi.org/10.1186/1471-2164-9-417.
54. Kasuga T, Townsend JP, Tian C, Gilbert LB, Mannhaupt G, Taylor JW, Glass NL. 2005. Long-oligomer microarray profiling in Neurospora crassa reveals the transcriptional program underlying biochemical and physiological events of conidial germination. Nucleic Acids Res 33:6469–6485. http://dx.doi.org/10.1093/nar/gki953.
55. Botts MR, Hull CM. 2010. Dueling in the lung: how Cryptococcus spores race the host for survival. Curr Opin Microbiol 13:437–442. http://dx.doi.org/10.1016/j.mib.2010.05.003.
56. Markovic J, Mora NJ, Broseta AM, Gimeno A, de-la-Concepción N, Viña J, Pallardó FV. 2009. The depletion of nuclear glutathione impairs cell proliferation in 3t3 fibroblasts. PLoS One 4:e6413. http://dx.doi.org/10.1371/journal.pone.0006413.
57. Sebastià J, Cristòfol R, Martín M, Rodríguez-Farré E, Sanfeliu C. 2003. Evaluation of fluorescent dyes for measuring intracellular glutathione content in primary cultures of human neurons and neuroblastoma SH-SY5Y. Cytometry 51:16–25. http://dx.doi.org/10.1002/cyto.a.10003.
58. Nishiuchi H, Tabira Y, Yamagishi K. 2012. A combination of flow cy-tometry and traditional screening using chemicals to isolate high glutathione-producing yeast mutants. Biosci Biotechnol Biochem 76: 1085–1090. http://dx.doi.org/10.1271/bbb.110883.
59. Nicola AM, Robertson EJ, Albuquerque P, Derengowski Lda S, Casa-devall A. 2011. Nonlytic exocytosis of Cryptococcus neoformans from mac-rophages occurs in vivo and is influenced by phagosomal pH. mBio 2:e00167–11. http://dx.doi.org/10.1128/mBio.00167-11.
60. Fortuniak A, Zadzinski R, Bilinski T, Bartosz G. 1996. Glutathione depletion in the yeast Saccharomyces cerevisiae. Biochem Mol Biol Int 38: 901–910.
61. Zadziński R, Fortuniak A, Biliński T, Grey M, Bartosz G. 1998. Mena-dione toxicity in Saccharomyces cerevisiae cells: activation by conjugation with glutathione. Biochem Mol Biol Int 44:747–759. http://dx.doi.org/10.1080/15216549800201792.
62. Valcourt JR, Lemons JM, Haley EM, Kojima M, Demuren OO, Coller HA. 2012. Staying alive: metabolic adaptations to quiescence. Cell Cycle 11:1680–1696. http://dx.doi.org/10.4161/cc.19879.
63. Zaragoza O, Nielsen K. 2013. Titan cells in Cryptococcus neoformans: cells with a giant impact. Curr Opin Microbiol 16:409–413. http://dx.doi.org/10.1016/j.mib.2013.03.006.
64. Panepinto J, Liu L, Ramos J, Zhu X, Valyi-Nagy T, Eksi S, Fu J, Jaffe HA, Wickes B, Williamson PR. 2005. The DEAD-box RNA helicase Vad1 regulates multiple virulence-associated genes in Cryptococcus neoformans. J Clin Invest 115:632–641. http://dx.doi.org/10.1172/JCI23048.
65. Fan W, Kraus PR, Boily M-J, Heitman J. 2005. Cryptococcus neoformans gene expression during murine macrophage infection. Eukaryot Cell 4:1420–1433. http://dx.doi.org/10.1128/EC.4.8.1420-1433.2005.
66. Hu G, Hacham M, Waterman SR, Panepinto J, Shin S, Liu X, Gibbons J, Valyi-Nagy T, Obara K, Jaffe HA, Ohsumi Y, Williamson PR. 2008. PI3K signaling of autophagy is required for starvation tolerance and virulence of Cryptococcus neoformans. J Clin Invest 118:1186–1197. http://dx.doi.org/10.1172/JCI32053.
67. Toffaletti DL, del Poeta M, Rude TH, Dietrich F, Perfect JR. 2003. Regulationof cytochromecoxidase subunit1(COX1) expression inCryp-tococcus neoformans by temperature and host environment. Microbiology 149:1041–1049. http://dx.doi.org/10.1099/mic.0.26021-0.
68. Ingavale SS, Chang YC, Lee H, McClelland CM, Leong ML, Kwon-Chung KJ. 2008. Importance of mitochondria in survival of Cryptococcus neoformans under low oxygen conditions and tolerance to cobalt-chloride. PLoS Pathog 4:e1000155. http://dx.doi.org/10.1371/journal.ppat.1000155.
69. Upadhya R, Campbell LT, Donlin MJ, Aurora R, Lodge JK. 2013. Global transcriptome profile of Cryptococcus neoformans during exposure to hydrogen peroxide induced oxidative stress. PLoS One 8:e55110. http://dx.doi.org/10.1371/journal.pone.0055110.
70. Voelz K, Johnston SA, Smith LM, Hall RA, Idnurm A, May RC. 2014. Division of labour in response to host oxidative burst drives a fatal Cryp-tococcus gattii outbreak. Nat Commun 5:5194. http://dx.doi.org/10.1038/ncomms6194.
71. Perfect JR, Lang SD, Durack DT. 1980. Chronic cryptococcal meningitis: a new experimental model in rabbits. Am J Pathol 101:177–194.
72. Ikeda R, Sawamura K. 2008. Bacterial and H2O2 stress-induced apoptosis-like events in Cryptococcus neoformans. Res Microbiol 159: 628–634. http://dx.doi.org/10.1016/j.resmic.2008.07.006.
73. Dromer F, Salamero J, Contrepois A, Carbon C, Yeni P. 1987. Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide. Infect Immun 55:742–748.
74. Murphy JW, Mosley RL, Cherniak R, Reyes GH, Kozel TR, Reiss E. 1988. Serological, electrophoretic, and biological properties of Cryptococ-cus neoformans antigens. Infect Immun 56:424–431.
75. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J. 2003. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34:374–378.
76. López S, Prieto M, Dijkstra J, Dhanoa MS, France J. 2004. Statistical evaluation of mathematical models for microbial growth. Int J Food Micro-biol 96:289–300. http://dx.doi.org/10.1016/j.ijfoodmicro.2004.03.026.
77. Janbon G, Maeng S, Yang D-H, Ko Y-J, Jung K-W, Moyrand F, Floyd A, Heitman J, Bahn Y-S. 2010. Characterizing the role of RNA silencing components in Cryptococcus neoformans. Fungal Genet Biol 47: 1070–1080. http://dx.doi.org/10.1016/j.fgb.2010.10.005.
78. Xue C, Liu T, Chen L, Li W, Liu I, Kronstad JW, Seyfang A, Heitman J. 2010. Role of an expanded inositol transporter repertoire in Cryptococ-cus neoformans sexual reproduction and virulence. mBio 1:e00084-10. http://dx.doi.org/10.1128/mBio.00084-10.
79. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45. http://dx.doi.org/10.1093/nar/29.9.e45.